CytoSorbents Analyst Ratings
CytoSorbents Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/04/2022 | 182.05% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 05/04/2022 | 207.69% | B. Riley Securities | $7 → $6 | Maintains | Buy |
| 05/04/2022 | 361.54% | HC Wainwright & Co. | $13 → $9 | Maintains | Buy |
| 09/17/2020 | 669.23% | Jefferies | → $15 | Initiates Coverage On | → Buy |
| 09/01/2020 | 669.23% | SVB Leerink | → $15 | Initiates Coverage On | → Outperform |
| 05/06/2020 | 720.51% | B. Riley Securities | $12 → $16 | Maintains | Buy |
| 05/06/2020 | 617.95% | HC Wainwright & Co. | $13 → $14 | Maintains | Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 11/04/2022 | 182.05% | HC Wainwright公司 | $9 → $5.5 | 維護 | 買 |
| 05/04/2022 | 207.69% | B.萊利證券 | $7 → $6 | 維護 | 買 |
| 05/04/2022 | 361.54% | HC Wainwright公司 | $13 → $9 | 維護 | 買 |
| 09/17/2020 | 669.23% | 傑富瑞 | → $15 | 開始承保 | →購買 |
| 09/01/2020 | 669.23% | SVB Leerink | → $15 | 開始承保 | →跑贏大盤 |
| 05/06/2020 | 720.51% | B.萊利證券 | $12 → $16 | 維護 | 買 |
| 05/06/2020 | 617.95% | HC Wainwright公司 | $13 → $14 | 維護 | 買 |
CytoSorbents Questions & Answers
細胞吸附網站問答
The latest price target for CytoSorbents (NASDAQ: CTSO) was reported by HC Wainwright & Co. on November 4, 2022. The analyst firm set a price target for $5.50 expecting CTSO to rise to within 12 months (a possible 182.05% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright&Co.於2022年11月4日報道了CytoSorbents(納斯達克代碼：CTSO)的最新目標價。這家分析公司將目標價定為5.5美元，預計CTSO將在12個月內上漲至(可能上漲182.05%)。3家分析公司在過去一年公佈了評級。
The latest analyst rating for CytoSorbents (NASDAQ: CTSO) was provided by HC Wainwright & Co., and CytoSorbents maintained their buy rating.
分析師對CytoSorbents(納斯達克代碼：CTSO)的最新評級由HC Wainwright&Co.提供，CytoSorbents維持買入評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CytoSorbents, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CytoSorbents was filed on November 4, 2022 so you should expect the next rating to be made available sometime around November 4, 2023.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查看公開的財務報表，與CytoSorbents的高管和客户交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。CytoSorbents的上一次評級是在2022年11月4日提交的，所以你應該預計下一次評級將在2023年11月4日左右的某個時候公佈。
While ratings are subjective and will change, the latest CytoSorbents (CTSO) rating was a maintained with a price target of $9.00 to $5.50. The current price CytoSorbents (CTSO) is trading at is $1.95, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的CytoSorbents(CTSO)評級保持不變，目標價在9.00美元至5.50美元之間。目前CytoSorbents(CTSO)的交易價格為1.95美元，超出了分析師的預測區間。